Pay in 4 interest-free payments of $70.62 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Volume 500 µL Syringe Type Gastight Syringe Series 1700 Termination Removable Needle (RN) Needle Large RN Gauge 22 gauge Point Style 3 Needle Length 0
Bis(6-methyl-1-heptyl) phthalate-3
4-Tetramethylanthracene
NUCLEOSIL CHIRAL-2/3
Decabromodiphenylethane
EC HPLC column (analytical), NUCLEODUR 100-3 CN-RP, 3 µm, 150x4 mm Method - Arsenic - Modified Gutzeit test Volume 500 µL Syringe TypeThe endcapped cyanopropyl phase is based on high purity NUCLEODUR silica gel. This HPLC phase is able to generate a clearly recognizable different retention behavior compared to purely alkyl functionalized surface modifications. The polarity can be classified as intermediate based on multiple retention mechanisms such as dipole dipole, , and also hydrophobic interactions. Therefore, this phase shows a distinct selectivity for polar organic compounds